Gregory C. Walker
Analyst · D.A
Thanks, John. As a reminder, in addition to using GAAP results when evaluating PDF's business, we believe it is also useful to consider our results using other non-GAAP measures. For internal purposes, the company focuses on non-GAAP net income and EBITDAR. Non-GAAP net income excludes stock-based compensation expenses; amortization of expenses related to acquired technology and other intangibles; restructuring charges and their related tax effects, as applicable. Additionally, the income tax provision has been adjusted in our non-GAAP income to reflect -- net income to reflect cash tax expenses only. EBITDAR is equal to earnings before income tax, adjusted to exclude depreciation, amortization, restructuring and stock-based compensation. You can access the earnings press release that contains a reconciliation of EBITDAR and non-GAAP net income to GAAP results in the Investors section of our website located at pdf.com. Now let's turn to a review of the financial results. Total revenues for the quarter were $27.1 million with a GAAP net income of $6.8 million. This resulted in GAAP EPS of $0.21 per fully diluted share, net income on a non-GAAP basis totaled $10.8 million or $0.34 per fully diluted share. Total cash increased by $4.1 million during the quarter. Also for the quarter, cost of sales and operating expenses together were $17.2 million on a GAAP basis and $15.2 million on a non-GAAP basis, which is a decrease in non-GAAP spending of approximately $591,000 from Q3. For the year, total revenues were $101.5 million and non-GAAP net income was $33.8 million. Overall, we are very pleased with the continued strength in the total revenues, earnings and cash for the quarter. Now moving on to revenue details. Total revenues of $27.1 million for the fourth quarter were up approximately $1.6 million as compared to $25.5 million in the prior quarter. Total revenues were comprised of design-to-silicon-yield solutions or solutions revenue of $14.9 million and gainshare performance incentives or gainshare revenue of $12.2 million. Our top 10 customers represented 94% of total revenues in the current quarter, slightly higher than in Q3. Three of these customers contributed revenues greater than 10% each for a total of 78% of the total, as compared to 75% in the prior quarter. Looking at solutions revenue in more detail. Twelve engagements with a total of 8 different customers each contributed at least $150,000 of solutions revenue in the quarter. Overall, solutions revenue at $14.9 million was a decrease of $2.1 million from the prior quarter. As discussed in our Q3 earnings call, the spike in Q3 solutions revenue was primarily the result of the closing of a large 14-nanometer R&D engagement and the onetime catch-up in revenues associated with that engagement. Gainshare revenue for the quarter was $12.2 million, an increase of $3.7 million over the prior quarter. The total number of customers contributing to gainshare in the quarter was 9, the same as in the previous quarter. For the year, total revenues were $101.5 million as compared to $89.5 million in the prior year, a year-over-year growth rate of 13%. Of the $101.5 million of total revenue, $39.7 million was gainshare revenue, which compared to $30.5 million of gainshare revenue in 2012. This reflects a year-over-year growth rate of 30%. Increasing volumes in the 28-nanometer node across our customer base drove the material increases in our gainshare revenues across all of our major customers. As we have previously discussed, the business model under which the company operates is designed such that a large portion of our gainshare revenue will contribute directly to EBITDAR and net income. On a geographic basis, in the quarter, North America accounted for 39% of total revenues, which is up 9% from the prior quarter. Europe accounted for 31% of total, up from 7% in the prior quarter. And Asia accounted for the remaining 30% of revenues, down 16% from the prior quarter. For the year, North America was 38% of total revenues, Asia represented 36% and Europe accounted for the remaining 27 -- 26%. Moving to expenses. Cost of sales for the quarter was $9.8 million on a GAAP basis, which was $941,000 lower than the prior quarter. As discussed in our Q3 earnings call, the spike in Q3 cost of sales was primarily the result of the closing of the large 14-nanometer R&D engagement that I talked about earlier and the onetime recognition of deferred costs associated with that engagement. For the full year, GAAP cost of sales was $39.5 million, an increase of $3 million or 8.1% over 2012. This increase was driven primarily by $1.3 million of deferred project costs from 2012 that were recognized during 2013, stock-based compensation increases of approximately $900,000 and depreciation and other equipment and software expense increases of about $1 million, partially offset by miscellaneous other expense reductions. For the fourth quarter and for the year, GAAP gross margin was 65% and 61%, respectively, compared to 59% in the prior quarter and for the prior year. The gross margin increase in the current quarter is reflective of the mix shift between solutions revenues and gainshare revenues. Our total GAAP operating expenses were $7.6 million or approximately 28% of total revenues compared to $7.2 million for the quarter or 28% of total revenues in the prior quarter. R&D expenses totaled $3.4 million, approximately the same as in the prior quarter. R&D expense as a percent of revenue was 12% in the quarter compared to 13% in Q3. SG&A expenses totaled $4 million or 15% of total revenues compared to $3.8 million in the same percent of revenue in Q3. Our total GAAP operating expenses for the year were $30.6 million or approximately 30% of revenues compared to $33.9 million or 38% of total revenues in 2013 -- 2012. For the year, increases in stock-based compensation were more than offset by reductions in restructuring costs, amortization expenses and reduced variable compensation expenses. R&D expenses totaled $13.3 million or 13% of revenues for the year compared to $13.3 million or 15% of revenues in the prior year. SG&A expenses totaled $17.1 million or 17% of total revenues compared to $18.8 million or 21% of total revenues in the prior year. On a non-GAAP basis, looking at operating expenses and cost of sales together, total expenses was $15.2 million versus $15.8 million in the prior quarter. Non-GAAP total expenses were lower compared to Q3 due to the previously mentioned recognition of deferred project costs in Q3, partially offset by an increase in variable compensation in Q4. For the year, non-GAAP operating expenses and cost of sales totaled $63.1 million compared to $63.2 million in the prior year. Restructuring charges recognized during the fourth quarter were $232,000. This expense reflects additional costs associated with the headcount and overhead reductions, primarily related to the reorganization of the company's VMS software organization announced in October of 2012. Items included in restructuring consist primarily of mandatory and the negotiated separation costs. For the quarter, other income and expense was an income of $45,000 compared to an expense of $23,000 in the previous quarter. For the year, other income and expense was an expense of $64,000 compared to an expense of $248,000 in 2012. The GAAP income tax provision for the quarter was $3.1 million, which reflects an estimated tax provision rate of 31.2%. This rate reflects the impact of increased R&D tax credits related to employee stock-based compensation being higher than expected. Of the $3.1 million, approximately $1.1 million represented cash tax liabilities. This represents an effective cash tax rate for the quarter of 11.6%. Our cash tax liability increased from the prior quarter by approximately $341,000 primarily due to foreign withholding taxes. For the year, the GAAP income tax provision was $10.4 million and cash tax liabilities were $4.5 million for a GAAP tax rate and a cash tax rate of 33.2% and 14.2%, respectively. For 2014, we expect that the GAAP tax rate to be in the range of 36% to 38% and the cash tax rate to be between 16% and 18%. Quarterly GAAP net income of $6.8 million resulted in GAAP EPS of $0.21 per fully diluted share as compared to $4.8 million or -- and $0.15 in the prior quarter. On a full year basis, GAAP net income of $20.9 million resulted in GAAP EPS of $0.67 per fully diluted share, a year-over-year decrease of $0.58 per share. This decrease is the result of the inclusion in the 2012 GAAP net income of $19.9 million or $0.67 per shares of benefit related to the partial release of our deferred tax allowances in 2012. Excluding the impact of this tax treatment, GAAP EPS would have increased year-over-year by approximately $0.09 per share. For detailed information on this release -- tax release, please refer to the Footnote #9 of our 2012 10-K. On a non-GAAP basis, net income was $10.8 million and non-GAAP EPS was $0.34 for the quarter compared to $8.6 million and $0.27, respectively, in the prior quarter. For the full year, non-GAAP net income was $33.8 million, resulting in non-GAAP EPS of $1.08. This compares to non-GAAP net income of $24.4 million and non-GAAP EPS of $0.82 in the prior year. EBITDAR, which I defined earlier and is also defined in our press release, was $12.3 million for the quarter and $39.7 million for the year as compared to $9.8 million for the prior quarter and $26.6 million in the prior year. EBITDAR per fully diluted share for the quarter was $0.39 per share compared to $0.31 per share in Q3. EBITDAR per fully diluted share for the year was $1.26 compared to $0.89 per share in 2012. As stated earlier, our EBITDAR per share benefited directly from the significant increase in gainshare revenues during the year. Total cash at the end of the quarter was $89.4 million, an increase of $4.1 million compared to September 30. This increase was driven by strong accounts receivable collections and proceeds from stock option exercises, partially offset by purchases of fixed assets primarily for our proprietary testers. Cash from operations during the quarter was $4.4 million. Year-over-year, total cash increased by $27.7 million. Trade accounts receivable days sales outstanding was 90 days for the quarter, a 16-day increase as compared to the previous quarter. This increase in DSO was driven by end-of-the-quarter billings directly related to increased gainshare revenues. Trade accounts receivable for the quarter was $26.9 million, an increase of $6.1 million over the prior quarter. Unbilled accounts receivable for the quarter was $8 million, an increase of $510,000 over the prior quarter. Of the $34.9 million of total receivables, $300,000 or less than 1% was more than 60 days past due. Total DSO for the quarter, including unbilled receivables, was 117 days compared to 101 days in the prior quarter, an increase of 16 days, once again primarily due to the timing of billing gainshare revenue at the end of the quarter as previously mentioned. Headcount at the end of Q4 was 363 employees on a worldwide basis compared to 369 at the end of Q3. This decrease was primarily related to the previously mentioned restructuring activity, partially offset by some hiring in Asia and North America. As with last quarter and last year, the overall financial results reflect continued strength in our core business and our ongoing attention to spending levels. We are very pleased with the results, and look forward to a successful 2014. This concludes the review of the financial results for the quarter. Now I will turn the call over to the operator for Q&A.